CAAT 20 Tablet
Marketer
Abbott
Salt Composition
Atorvastatin (20mg)
Overview CAAT 20 Tablet
CAAT 20, a statin medication, effectively lowers cholesterol levels, thus mitigating the risk of cardiovascular events. High cholesterol, a fatty substance accumulating in blood vessels, causes narrowing and potentially heart attacks or strokes. Widely prescribed and generally considered safe for prolonged use under medical supervision, CAAT 20 can be administered with or without food at any time of day, ideally consistently. While high cholesterol often presents no symptoms, discontinuing treatment elevates cholesterol, increasing heart disease and stroke risk. Regular cholesterol monitoring is crucial. Treatment encompasses lifestyle changes: balanced diet, regular physical activity, smoking cessation, moderate alcohol consumption, and weight management. Maintain a normal diet, minimizing high-fat foods. Common, typically mild and transient, side effects include constipation, gas, indigestion, and stomach pain. Persistent symptoms, jaundice, or recurring unexplained muscle aches necessitate immediate medical consultation. Contraindicated in liver disease, pregnancy, and breastfeeding due to potential fetal harm, CAAT 20 may also elevate blood sugar in diabetics, requiring careful blood glucose monitoring. Liver function tests are usually conducted before and during treatment.
Uses of CAAT 20 Tablet
Elevated cholesterol levels|Reducing heart attack risk
Major Benefits of CAAT 20 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. CAAT 20 Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of CAAT 20 Tablet:
- Dyspepsia
- Abdominal pain
- Indigestion
- Diarrhea
- Joint pain
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Pain in extremities
- Urinary tract infection
- Abnormal liver function tests
How to use CAAT 20 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. CAAT 20 Tablets can be consumed with or without food; however, consistent timing is recommended.
How CAAT 20 Tablet works:
CAAT 20 tablets contain a statin, a drug that reduces cholesterol levels. This medication inhibits HMG-CoA reductase, an enzyme crucial for cholesterol production. Consequently, it decreases levels of LDL cholesterol ("bad" cholesterol) and triglycerides, while increasing HDL cholesterol ("good" cholesterol).
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with CAAT 20 Tablet requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
The use of CAAT 20 Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician immediately, as research in both animal models and human studies has revealed substantial risks to fetal development.
Breast feedingUNSAFE
Administering CAAT 20 Tablet while breastfeeding is contraindicated. Evidence indicates potential infant toxicity.
DrivingSAFE
Driving ability is typically unaffected by CAAT 20 Tablet.
KidneySAFE IF PRESCRIBED
CAAT 20 Tablet poses no known safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advisable.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using CAAT 20 Tablet, as dose modification may be necessary. Consult a physician before use. CAAT 20 Tablet is contraindicated in patients experiencing severe or active liver disease.
What if you forget to take CAAT 20 Tablet :
Should you forget a CAAT 20 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking two doses within a 12-hour period.
Facts to Know About CAAT 20 Tablet
| Label | Value |
|---|---|
| Type of Compound | Compound derived from pyrrole and heptanoic acid |
| Potential for Dependence | None. |
| Medication Classification | HEART |
| Mechanism of Action | 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors |






